426 related articles for article (PubMed ID: 34351939)
21. Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.
Brand A; Visser ME; Schoonees A; Naude CE
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015207. PubMed ID: 35944931
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.
Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Marx N; Sliwa K; Weber MA; Williams B; Yusuf S
Eur Heart J; 2019 Jul; 40(25):2032-2043. PubMed ID: 30919899
[TBL] [Abstract][Full Text] [Related]
23. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Saiz LC; Gorricho J; Garjón J; Celaya MC; Muruzábal L; Malón MDM; Montoya R; López A
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD010315. PubMed ID: 29020435
[TBL] [Abstract][Full Text] [Related]
24. Achieving blood pressure control targets in hypertensive patients of rural China - a pilot randomized trial.
Huang X; Liu L; Song Y; Gao L; Zhao M; Bao H; Qin X; Wu Y; Wu Q; Bi C; Yue A; Fang C; Ma H; Cui Y; Tang G; Li P; Zhang Y; Li J; Wang B; Xu X; Wang H; Parati G; Spence JD; Wang X; Huo Y; Chen G; Cheng X;
Trials; 2020 Jun; 21(1):515. PubMed ID: 32527283
[TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapy for hyperuricaemia in hypertensive patients.
Gois PHF; Souza ERM
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD008652. PubMed ID: 32877573
[TBL] [Abstract][Full Text] [Related]
26. A Resilience-Based Intervention to Mitigate the Effect of HIV-Related Stigma: Protocol for a Stepped Wedge Cluster Randomized Trial.
Li X; Qiao S; Yang X; Harrison SE; Tam CC; Shen Z; Zhou Y
Front Public Health; 2022; 10():857635. PubMed ID: 35425746
[TBL] [Abstract][Full Text] [Related]
27. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Böhm M; Schumacher H; Teo KK; Lonn E; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder R; Weber M; Sliwa K; Williams B; Yusuf S
Eur Heart J; 2018 Sep; 39(33):3105-3114. PubMed ID: 29873709
[TBL] [Abstract][Full Text] [Related]
28. Integration of a multicomponent intervention for hypertension into primary healthcare services in Singapore-A cluster randomized controlled trial.
Jafar TH; Tan NC; Shirore RM; Allen JC; Finkelstein EA; Hwang SW; Koong AYL; Moey PKS; Kang GC; Goh CWT; Subramanian RC; Thiagarajah AG; Ramakrishnan C; Lim CW; Liu J;
PLoS Med; 2022 Jun; 19(6):e1004026. PubMed ID: 35696440
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes of pharmaceutical care intervention in HIV positive patients with hypertension: A randomized controlled study.
Jackson IL; Ukwe CV
J Clin Pharm Ther; 2021 Aug; 46(4):1083-1094. PubMed ID: 33666264
[TBL] [Abstract][Full Text] [Related]
30. Pharmacotherapy for hyperuricemia in hypertensive patients.
Gois PHF; Souza ERM
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD008652. PubMed ID: 28406263
[TBL] [Abstract][Full Text] [Related]
31. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
[TBL] [Abstract][Full Text] [Related]
32. Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-Pacific Region.
Arima H; Murakami Y; Lam TH; Kim HC; Ueshima H; Woo J; Suh I; Fang X; Woodward M;
Hypertension; 2012 Jun; 59(6):1118-23. PubMed ID: 22547441
[TBL] [Abstract][Full Text] [Related]
33. Moxibustion for prehypertension and stage I hypertension: a pilot randomized controlled trial.
Shin KM; Park JE; Yook TH; Kim JU; Kwon O; Choi SM
Integr Med Res; 2019 Mar; 8(1):1-7. PubMed ID: 30596012
[TBL] [Abstract][Full Text] [Related]
34. Alcohol intake reduction for controlling hypertension.
Acin MT; Rueda JR; Saiz LC; Parent Mathias V; Alzueta N; Solà I; Garjón J; Erviti J
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010022. PubMed ID: 32960976
[TBL] [Abstract][Full Text] [Related]
35. Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension.
Wong GW; Boyda HN; Wright JM
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD007450. PubMed ID: 25427719
[TBL] [Abstract][Full Text] [Related]
36. Research protocol: effect of natural S-equol on blood pressure and vascular function--a six-month randomized controlled trial among equol non-producers of postmenopausal women with prehypertension or untreated stage 1 hypertension.
Liu ZM; Ho SC; Chen YM; Xie YJ; Huang ZG; Ling WH
BMC Complement Altern Med; 2016 Mar; 16():89. PubMed ID: 26928904
[TBL] [Abstract][Full Text] [Related]
37. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Saiz LC; Gorricho J; Garjón J; Celaya MC; Erviti J; Leache L
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD010315. PubMed ID: 36398903
[TBL] [Abstract][Full Text] [Related]
38. Chronic effect of resistance training on blood pressure in older adults with prehypertension and hypertension: A systematic review and meta-analysis.
Henkin JS; Pinto RS; Machado CLF; Wilhelm EN
Exp Gerontol; 2023 Jun; 177():112193. PubMed ID: 37121334
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
[TBL] [Abstract][Full Text] [Related]
40. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
